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Abstract  
The adsorption of antibody onto gold nanoparticles to make gold-antibody conjugates is finding 
application in multiple areas.  Gold-antibody conjugates for use in malaria diagnostics were prepared 
and a method of characterisation that can be applied to any gold-protein conjugate was developed.  
When protein adsorbs onto a gold nanoparticle, it changes the local refractive index and so changes the 
surface plasmon resonance of the gold particle.  Changes to the surface plasmon resonance manifest in 
the absorbance spectrum of the conjugates.  This was measured this by optical spectroscopy and 
relatively simple equations to convert spectral shifts to predictions of the protein layer thickness and 
mass coverage are presented.  As with most protein adsorption reported in the literature, the results 
showed the protein adsorption to depend on antibody concentration, reaching a plateau at around 1 µg 
ml-1.  The coverage was estimated to be approximately 2-3 mg m-2 and the coating thickness estimates 
were approximately 10 nm, which is consistent with active antibody.  The results suggested more 
antibody was used in conjugate preparation than was necessary for complete coverage of the gold.  
This excess antibody could bind to the target antigen to reduce malaria test sensitivity.  A key 
advantage of this characterisation method is that it is sufficiently simple to be used for quality control 
of conjugate production and the equations presented can be applied to other coatings on gold 
nanoparticles. 
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Introduction 
Coating of materials onto gold nanoparticles find multiple applications in bio-sciences
1,2
.  The strong 
colour of gold nanoparticles makes them suitable for visual observation, and is caused by the particular 
optical properties of gold, which was first systematically explained by Mie
3
.  The colour is also stable; 
gold nanoparticles do not suffer from photobleaching, unlike organic dyes
4
.  A particularly important 
application of coated gold nanoparticles is that of rapid diagnostic kits, where the colour of the gold is 
used by the user of the kit to observe bands indicating whether the analyte is present.  These kits find 
particular application in the tropics, where a 'low-technology' diagnostic is useful
5,6
.  The specific 
diagnostic application that motivated the work described herein was a rapid diagnostic against malaria
7
. 
A representation of the rapid malaria diagnostic in use is shown in Figure 1.  The kit detects 
pLDH (plasmodium lactate dehydrogenase), a protein that circulates in the blood if a patient has a 
malaria infection
7
.  A small blood sample is taken from the patient by a finger prick and then mixed 
with the antibody-coated gold particles.  This antibody binds to pLDH.  The conjugate then soaks up 
the nitrocellulose test strip, where there is a band of a second antibody to pLDH.  If the patient has 
malaria, the pLDH protein will bind to both antibodies and so causes a band of gold nanoparticles to be 
visible on the test strip.   
FIGURE 1 
From this a number of critical factors for the success of the diagnostic can be identified: (i) 
both antibodies need to be biologically active and (ii) the antibodies bound to the gold nanoparticles 
need to have the antigen binding sites available, namely the orientation is important.  Also, if there is 
unbound antibody present in the conjugate solution, it will competitively bind to the pLDH malaria 
protein preventing binding to the gold and so reduce the sensitivity of the test kit. 
Many field tests of rapid diagnostics have been conducted with differing levels of success with 
little definite explanation of the differences8.  Also for commercialisation of the rapid diagnostics, 
simple quality control tests of the coated nanoparticles is essential. 
The surface plasmon resonance that gives gold nanoparticles their strong colour is utilised 
here to measure the antibody coating thickness.  Theoretical predictions show how the local refractive 
index environment of the particle affects its absorption spectrum.  The coverage of a protein coating 
determines the change in local environment, which has been used here as a measurement tool.  Here we 
measure changes in the spectrum of gold colloids with absorbed antibody, with simple laboratory 
equipment.  This work aims to apply the physics of light absorption and scattering to the gold colloid 
and to present equations so this experimentally simple technique can be applied by others to the diverse 
range of applications of coated gold colloids. 
1 Theory 
The interaction of light with gold particles causes oscillations of the unbound valence electrons of the 
metal.  Absorption and scattering become large close to the resonance of the electrons.  Hence the 
phenomenon is termed surface plasmon resonance, where a plasmon is a quantised charge density 
wave
9
.  Gold colloids are coloured as absorption and scattering depends on wavelength.  This is 
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manifested by the complex refractive index being a strong function of the wavelength of incident 
light
10
.   
The absorbance and scattering of a particle depends on the local dielectric environment, as 
shown by Mulvaney
11
 and Mock et al.
12
 with solvents of different refractive indices.  The local 
dielectric environment also changes when the particle is coated because proteins have a higher 
refractive index than water.  The changes to absorption and scattering are manifested as changes to the 
wavelength of maximum absorption (λmax) and peak absorbance (Amax).   
Changes to λmax were considered by various authors
13,14
 (see Appendix for details) by 
assuming the protein coated nanoparticles were spheres with a homogeneous spherical shell.  The 
Rayleigh limit was also assumed. Comparing the case of an uncoated 50 nm gold particle to the exact 
Mie solution, the error in the wavelength of maximum absorption (λmax) was only 0.3 % but 
approximately 30 % for Amax.  The predicted change in λmax namely ∆λ is given by Equation 1. 
( )
( )( )∆λ
λ ε ε
λ α
=
−
+ −
p s m
s
g
g
2
0 1 2 1max,
 (1) 
The terms in this equation are all known: λp is the free electron oscillation wavelength, which 
is 131 nm for gold
15
; ε is a dielectric constant or relative permittivity (equal to the refractive index 
squared) and the subscripts s and m refer to the shell and surrounding medium respectively; g is the 
fraction of the total particle that is shell; λmax,0 is the wavelength of maximum absorption for uncoated 
colloid and αs = (εs-εm)/(εs+2εm) (polarizability of a sphere of shell dielectric constant εs in a medium of 
dielectric constant εm). 
In this work it was desired to find the coating thickness from the spectral changes, so Equation 
1 was inverted: 
 (2) 
The coating thickness (s) can be calculated from the shell fraction (g) and core diameter (d) by 
geometry: 
 (3) 
Equations for the change in peak absorbance (∆A) with coating are also given in the appendix.  The 
mass of protein absorbed per unit area (coverage, Γ) is of interest as well as the coating thickness.  This 
can be calculated using de Feijter’s formula
16
: 
Γ =
−
s
n n
dn dc
s m
/
 (4) 
Where, n is the refractive index (for the shell (ns) and the surrounding medium (nm), which in this 
system is essentially water, which has a refractive index of 1.335 at 550 nm) and dn/dc is the refractive 
index increment (typically 0.19 ml/g for protein
17
) 
A key advantage of Equation 2 is that it is sufficiently simple to be solved for a given set of 
spectral data on a spreadsheet.  However, the refractive index of the shell, in this case the adsorbed 
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antibody layer needs to be estimated.  The refractive index of the protein coating is lower than that of 
dry protein due to entrapped water within the layer
18
.  Dry protein has a refractive index in the region 
of 1.5 to 1.618-20.  Zhou et al.21 assumed a refractive index for pure protein between 1.450 and 1.465.  
For an IgG layer (on a hydrophobic surface), Lassen and Malmsten
22
 used ellipsometry to show that the 
layer refractive index to vary with coverage (1.34 to 1.39), consistent with a decreasing fraction of 
water in the layer.  Estimates of refractive index ranged from 1.40 to 1.44 for IgG on gold 
nanoparticles, using a combination of spectral changes and dynamic light scattering (DLS), 
nanoparticle tracking analysis (NTA) and differential centrifugation sedimentation (DCS)
23
.  A 
combination of optical waveguide lightmode spectroscopy (OWLS) and a quartz crystal microbalance 
(QCM) was used by Vörös
24
 to measure IgG coverage and adsorbed mass including water respectively.  
From these the density of the layer and so its refractive index was found as 1.38 on 
poly(tetrafluoroethylene) and 1.42 on TiO2.   
Equation 3 is plotted in Figure 2A, for different possible shell refractive indices, and shows 
the impact of this uncertainty in refractive index: a shell of a given thickness causes more peak shift 
(∆λ) if it has a higher refractive index.  The calculated coverage (Γ), shown in Figure 2B, is much less 
sensitive to the value of protein refractive index (ns) used than the calculated layer thickness (s).  This 
is because the terms with strong ns dependence: (ns – nm) in Equation 4 and (εs – εm) in Equation 3 
partially cancel.  In Figure 2C, these data were re-plotted to directly observe the effect of shell 
refractive index on the shell thickness from an example set of spectral data.  From Figure 2C it is 
notable that the layer thickness curves calculated from ∆λ and ∆A are roughly parallel.  If they 
intersected cleanly, the combination of ∆λ and ∆A could be used to find both the coating thickness and 
refractive index.  However, roughly the same information is gained from both ∆λ and ∆A, so ns is 
required to find s.  The lower sensitivity to shell refractive index in the calculation of coverage can also 
be observed. 
FIGURE 2 
2 Materials and Methods 
Colloidal gold was prepared by a modification to the Frens25 method.  All glassware was first cleaned 
using aqua regia, to remove any initial traces of gold colloid that would serve as nucleation centres, 
rinsed with deionised water and oven dried.  Deionised water (100 ml) and HAuCl4•3H2O (10 mg ml
-1
, 
1.0 ml, Sigma) were mixed and boiled under reflux with constant stirring.  Na3-citrate•2H2O (10 mg 
ml
-1
, 12.0 ml, Sigma) was added and boiled for 2 min.  The solution was pale pink at the end of this 
step (nucleation).  HAuCl4•3H2O (10 mg ml
-1
, 8.4 ml) was added and the solution turned black after 
approximately 10 s and then opaque purple after a further 10 s.  Boiling was continued for 2 min.  All 
reagent solutions were filtered (0.22 µm, Millipore Express PES) prior to addition.   
The particle size of the gold colloid was measured by Transmission Electron Microscopy 
(FEI-Philips, Eindhoven, Netherlands, BioTwin CM120 with a Lab 6 emitter and 120 kV accelerating 
potential), as 52.6 nm (number mean) with a standard deviation of 10.0 nm.  The particles were roughly 
spherical and approximately normally distributed.  The size measurement was repeated one year after 
preparation and no significant difference in size was found, indicating a stable colloid. 
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The concentration of the colloid was found by assuming complete reduction of the HAuCl4
25-
26
.  The mass concentration of gold in all batches was 387 µg ml
-1
, volume concentration 
2.01×10-5 m3 m-3 (20 ppmv) and for 50 nm diameter particles, a molar particle concentration of 0.5 nM. 
Conjugates were prepared at various concentrations of antibody.  Antibody (type 6C9, a kind 
gift of Mike Makler of Flow Inc., 40 µl, 1.6 to 200 µg ml
-1
) was mixed with Tris-HCl buffer (40 µl, 0.1 
M, pH 8.4) and gold colloid (200 µl).  Colloid only controls were prepared in the same manner, but 
with the antibody replaced by buffer.  The samples were diluted ten fold and the visible spectrum was 
measured using a Cary 3E spectrophotometer (Varian, Palo Alto, CA) with 0.2 nm spectral bandwidth, 
0.1 nm resolution and 0.1 s (3 chopper cycles) averaging per point.  On this instrument, the 
monochromator is a diffraction grating and the detector is a photomultiplier tube.  Repeat 
measurements included repeating the antibody conjugation step rather than just the spectroscopy.  The 
peak absorbance (λmax) was found by fitting a quadratic equation (least squares method) to the 
absorbance from 530 to 565 nm and the maximum found by differentiation.  This was found to result in 
a lower standard deviation in λmax than by using the peak of the raw data because the fitting smooths 
noise from the spectrum. 
3 Results and Discussion 
An example of the raw optical density data for both uncoated gold colloid and conjugates is shown in 
Figure 3.  A peak at approximately 550 nm is observed, which gives the colloid used for this work its 
distinctive purple colour.  Note that the absorbance spectrum of gold colloid depends on particle size, 
so smaller, more common gold colloids have a red colour.  For the purposes of a rapid diagnostic, 
larger gold is advantageous because the colour is more intense per surface area, so maximising the 
sensitivity.  The red shift in the peak absorbance wavelength on conjugation (λmax increase) is difficult 
to see by eye, but can be observed by the quadratic fitting method in Figure 4.   
FIGURES 3-4 
If the red-shift was caused by coagulation of the colloid (rather than antibody conjugation to 
the gold) then the peak absorbance would fall and would cause an increase in absorbance at 
approximately 750 nm from the absorbance of the aggregates27.  However, as Figure 3 shows the 
absorbance of the conjugates between 700 and 800 nm is slightly lower than for the uncoated colloid 
and Figure 3 shows an increase in Amax on conjugation, so coagulation as the cause of red-shift can be 
discounted.  
The data in Figure 3 were used with Equation 4 to calculate the antibody coverage on the gold 
at the different bulk antibody concentrations, with results shown in Figure 5. Small changes in the 
medium refractive index (nm) from buffer solute and unadsorbed protein have a negligible effect on λmax 
(check via Equation A10) and contributions from adsorbed citrate (residue from the colloid 
preparation) are negligible due to the small size of the citrate molecule. 
The measurements of coverage (Figure 5) are broadly consistent with the variety of 
measurements of antibody adsorption reported in the literature
21,28-31
.  Figure 5 shows that at the low 
concentrations, the estimated coverage is larger than that predicted from assuming all of the antibody is 
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adsorbed onto the theoretical surface area of the gold colloid.  Changes to the layer refractive index (ns) 
can not eliminate this observation.   
FIGURE 5 
The five lowest concentrations in Figure 5 correspond to between 4 and 65 antibody 
molecules per gold particle.  To put this in perspective, a coverage of 2.6 mg m
-2
 for end-on 
orientation31 corresponds to approximately 80 antibody molecules on a 50 nm particle.  Therefore, for 
the concentrations studied in Figure 5, it is likely that only parts of the surface will be covered.   
It is postulated that a gold particle with isolated adsorbed antibody molecules has the optical 
properties as if there was a shell of molecules and so the coverage is overestimated by Equation 4.  
Rather than using Equations 1-4, it is possible (but more complicated) to model the coated spheres 
using the Mie model and the heterogeneous coating as a series of many homogeneous layers32-33.  
However, the more complicated models seems to have little merit when the unknown refractive index 
of the layer is so significant in the layer thickness calculation (see Figure 2).  No models considering 
partial coatings have been found in the literature.   
Figure 5 also shows that at higher antibody concentrations, the coverage is less than predicted 
from complete adsorption, implying there is unadsorbed antibody.  The higher concentrations were 
investigated because they are needed to prevent sodium chloride agglutination of the nanoparticles, 
which is the traditional method of determining the appropriate amount of antibody to add
34
.  From the 
perspective of the diagnostic kit, these concentrations need to be avoided: (1) the un-adsorbed antibody 
will competitively or preferentially interact with the test protein thus reducing the sensitivity of the test 
and (2) if more antibody is used than needed for complete coverage, this increases the cost of the kit. 
The conformation of the adsorbed antibody is critical in determining whether it is biologically 
active.  Ideally, the Fc region would be absorbed to the surface and the antigen binding Fab regions are 
free to bind to the antigen rather than also being adsorbed to the surface. Therefore, the 'end-on' 
conformation is desired over the 'side-on' conformation
35
.  An active antibody molecule is a 'Y' shape 
and the size has been estimated by many authors, with the long length as approximately 12-14 nm
21,36
, 
so an active antibody coating ('end-on' conformation) should have a thickness of approximately 12 nm.  
Thinner coatings of around 6 nm would correspond to the 'side-on' conformation.  The layer thickness 
was calculated from the peak shifts using Equations 2 and 3 and results are shown in Figure 6.  They 
show the shell thickness (s) of approximately 10 nm and independent of antibody concentration, above 
approximately 1 µg ml
-1
.  This nearly corresponds to end-on antibody size (12 nm).  However, if the 
layer refractive index (ns) is 1.40 rather than 1.38 then the coating thickness is approximately 6 nm, 
which is closer to the side-on orientation.  Also, the layer refractive index (ns) depends on the water 
content of the layer
18, 23
 which is not necessarily constant with antibody concentration.  However if ns 
changes, it is likely to increase with protein concentration; that is, because of less water in the protein 
layer.  This would correspond to thinner layers at higher concentrations (Figure 2A), which seems 
unlikely physically.  Therefore, a key problem with the method is the sensitivity to layer refractive 
index.  However for antibodies, a refractive index of 1.38 appears to be a more accurate estimate than 
1.40 for the refractive index.  Hence this method for determining coating thickness for antibody coating 
potentially has wide application.   
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FIGURE 6 
As proteins are anisotropic, the refractive index will depend on the orientation (birefringence, 
a feature exploited in circular dichroism spectroscopy).  Therefore the protein layer refractive index 
will depend on the orientation of the molecules.  However, the magnitude of the birefringence is 
unknown and was not measured by Lassen and Malmsten
22
 or by Vörös
24
.  The birefringence is 
assumed to be negligible compared to the changes in refractive index from the water content of the 
protein layer. 
There have been other measurements of antibody film thicknesses, such as 3-7 nm (depending 
on concentration) on gold by quartz crystal microbalance and surface acoustic wave and 6 nm by 
AFM
21
; a 2-2.5 nm layer thickness on mica measured by AFM
37
 and 4 nm on silica by neutron 
reflection29.  Comparisons are difficult because of the ns uncertainty for the results presented here and 
that other measurements have been made on flat surfaces rather than particles.  Bell et al.
23
 used a wide 
range of antibody concentrations (0.1 µg/ml to 1 mg/ml) and measured a range of thicknesses using 
DLS, NTA and DCS up to approximately 12 nm. 
This technique could also be applied to other metallic particles that have a plasmon resonance, 
such as silver.  The equations for absorbance changes on coating should still apply, but refractive index 
data for the other metal would need to be used.  Non-metallic particles typically do not have an 
absorbance maximum, so the only optical changes on absorption would be an increase in scattering 
from the larger particle size.  Analytically this would be difficult to exploit as a low wavelength would 
have to be used and this is sensitive to dust.  Also, the equation derived for the peak shift (Equation 1) 
does not apply because the dielectric constant of non-metallic particles does not follow the Drude 
model (Equation A8)
9
. 
4 Conclusion 
This method gives an estimate of the antibody coverage in a non-invasive way and has shown that a 
layer is definitely formed on the gold colloid.  The main difficulty with the method is the sensitivity of 
the result to the protein layer refractive index, which must be determined by other means and possible 
problems when the coverage is so low that the adsorbed antibody molecules are isolated from each 
other.  For antibodies, the best estimate of the refractive index is 1.38.  Absorbance peak shifts have 
been used before to consider protein binding to gold colloids
14,18,32
 and antigen binding to adsorbed 
antibodies9,38,39.  However, this work represents the first to show the sensitivity of the thickness 
measurement to protein layer refractive index and that coverage can also be calculated.  The coverage 
measurement is less sensitive to protein refractive index.   
Considering implications for the diagnostic kit, the most likely conformation of the protein is 
end-on, which should retain antibody activity.  The derived protein coverage shows excess antibody 
was used, which reduces the sensitivity of the rapid diagnostic.  The method is sufficiently simple to be 
used for quality control of antibody conjugate production and the equations presented can be applied to 
other coatings on gold nanoparticles. 
Page 8 of 18RSC Advances
R
S
C
A
dv
an
ce
s
A
cc
ep
te
d
M
an
us
cr
ip
t
 9 
Acknowledgements 
The authors would like to thank the UCL School of Pharmacy for a PhD studentship for MJP and Mike 
Makler of Flow Inc. for the gift of the antibody.  SB is grateful for funding from the UK Engineering & 
Physical Sciences Research Council (EPSRC) for the EPSRC Centre for Innovative Manufacturing in 
Emergent Macromolecular Therapies. Financial support from the consortium of industrial and 
governmental users for the EPSRC Centre is also acknowledged.  SB is also grateful for funding from 
NIHR Biomedical Research Centre at Moorfields Hospital and the UCL Institute of Ophthalmology, 
Moorfields Special Trustees, the Helen Hamlyn Trust (in memory of Paul Hamlyn), Fight for Sight and 
Freemasons Grand Charity.   
Financial Interest Statement: The authors declare no competing financial interest 
 
 
5 Theory Appendix 
This appendix considers the derivation of Equation 1 (variation in the wavelength of peak absorption, 
λmax, with coating thickness) and the equivalent equation for the peak absorption, Amax.   
The absorbance of any monodisperse colloid is given by Equation A1, where A is the 
absorbance, N is the number of particles and l is the path length.  Cext is the extinction cross section, 
that is the equivalent area blocked by each particle11. 
A
NC lext=
2 303.
 (A1) 
Considering the relative change in absorbance (∆A/A) allows factors such as concentration to cancel as 
this remained constant.  Equation A2 is obtained, where the subscript 0 refers to uncoated particles: 
A A
A
A
A
C
C
conjugate ext conjugate
ext
−
= = −
0
0 0
1
∆ ,
,
 (A2) 
Cext is the sum of two components, absorption (Cabs) and scattering (Csca), as given by Equations A3 to 
A5
9,15,40 
( ) ( )( )
C
d s n F
abs
solvent=
+π ε
λ
2 32 Im
 (A3) 
( ) ( )C
n
d s Fsca
solvent=





 +
2
3
2
4
6 2π π
λ
ε  (A4) 
( )
( )( ) ( )( )
( )( ) ( )( )F
f
f
s m c s c s m s
s m c s s m c s
ε
ε ε ε ε ε ε ε ε
ε ε ε ε ε ε ε ε
=
− + + − +
+ + + − −
2 2
2 2 2
 (A5) 
Other authors11,13,15 do not consider the scattering term as it is small in the Rayleigh limit, 
which is valid for small gold particles.  As 50 nm diameter gold particles are at the borderline or 
outside the Rayleigh limit the scattering term was included and contributes approximately 20 % of the 
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extinction.  Hence optical density is a more accurate term for the extinction measured on a 
spectrometer but the symbol A is still used. 
To find λmax the expression for the extinction coefficient (Cext) is maximised by setting the 
denominator of Equation A5 to zero (as shown in Equation A6) and solving for εs , the dielectric 
constant of the core, which for gold is a strong function of wavelength. 
( )( ) ( )( )ε ε ε ε ε ε ε εs m c s s m c sf+ + + − − =2 2 2 0  (A6) 
( ) ( )
( ) ( )ε ε
ε ε
ε ε
ε
α
αc s
s m
s m
s
s
s
f f
f f
f
f
= −
− + +
+ + −
= −
−
+
2
1 2
1 2 2 1
2
1
1 2
 (A7) 
To relate the dielectric constant (εc) to λmax, the Drude dielectric function is used.  This 
function models the free electrons in the conductor (gold) as a simple harmonic oscillator about the 
nuclei.  As the shell and medium are non-absorbing, Equation A7 refers to real part of the dielectric 
constant (ε') the expression for which, by the Drude model, is given by Equation A8.  The free electron 
oscillation wavelength is λp (dependent on the free electron density), c is the speed of light (in vacuum) 
and γ is a damping factor
9
.   
ε
π
λ
π
λ γ
'= −








 

 +
1
2
2
2
2
2
c
c
p
 (A8) 
An approximation to this function is used given by Equation A9 where ε∞ is the interband contribution 
to the dielectric function
13
: 
ε ε
λ
λ
'= −∞
2
2
p
 (A9) 
This approximation for ε was also compared to experimental values of ε' for gold and found to be a 
reasonable match around λmax.  Note that the approximation used by Bohren and Huffman
9 is not a good 
approximation for gold at those wavelengths. 
By considering the difference in dielectric constant between coated spheres (Equation A7) and 
uncoated spheres (εc = -2εm.), Equation A10 is derived, where f is the fraction of the total particle that is 
core: 
( ) ( )
( ) ( )ε ε
λ
λ
λ
λ
ε
ε ε
ε ε
εc m
p p
s
s m
s m
m
f f
f f
+ = − = −
− + +
+ + −
+2 2
1 2
1 2 2 1
2
2
2
0
2
2
max max,
 (A10) 
 
By substituting g = 1 – f, λmax = λmax,0 + ∆λ noting that λmax ≈ λmax,0 so λ
2
 – λmax,0
2
 ≈ 2λmax,0∆λ and 
rearranging: 
( )
( )( )∆λ
λ ε ε
λ α
=
−
+ −
p s m
s
g
g
2
0 1 2 1max,
 (1) 
The peak absorbance (Amax) is found by substituting the value of εc at λmax into Equations A3 to A5. 
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Graphical abstract for the table of contents 
 
 
 
Coating thickness estimates of coated gold nanoparticles was achieved to avoid reduction of diagnostic 
sensitivity from excess antibody. 
 
 
Figure 1 
 
 
 
 
Figure 1.  Ilustration of the malaria rapid diagnostic with bound malaria protein (pLHD) linking the 
gold to a localised region on the nitrocellulose test strip. 
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Figure 2 
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Figure 2.  A: Predictions of coating thickness (s) from spectral changes.  B: Predictions of coverage 
(Γ).  C: Impact of shell refractive index (ns) on the predictions.  All predictions are for 50 nm gold 
particles. 
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Figure 3 
 
 
 
Figure 3.  Changes to the UV-visible extinction spectrum on conjugation.  All samples were ten fold 
diluted prior to measurement.  These spectra only were measured with 1 nm resolution and 2 nm 
spectral bandwidth.  Note that the spectrometer has a source change at 350 nm. 
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Figure 4 
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Figure 4.  Variation in conjugate peak absorbance with antibody concentration.  Wavelength (×, λmax), 
Optical density (□, Amax).  Mean ± SD, n = 3 preparations. 
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Figure 5.  Variations in antibody coverage on gold colloid with antibody concentration (×) found from 
changes in λmax and assuming ns = 1.38.  The line represents the coverage if all antibody is adsorbed.  
Mean ± SD, n = 3, error bars do not include the uncertainty in coating refractive index. 
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Figure 6.  Antibody coating thickness on gold colloid found from changes in λmax and assuming a 
coating refractive index (ns) of 1.38.   Mean ± SD, n = 3, error bars do not include the uncertainty in 
coating refractive index. 
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